RAFAEL HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
RAFAEL HOLDINGS, INC. (RFL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 217.93 thousand shares for the 9-month period ending 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2023-06-13
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-04-30 was 0.00 shares, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2022-07-31 was 0.00 shares.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2022-04-30 was 5.50K shares.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2022-01-31 was 171.54K shares, a 17070.97% increase year-over-year.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 180.44K shares, a 13538.78% increase from fiscal 2021.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2021 was 1.32K shares, a 410.81% increase from fiscal 2020.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2020 was 259.00 shares, a 68.38% decline from fiscal 2019.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2019 was 819.00 shares, a 898.78% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2023-04-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | 217.93K shares 10-Q · filed 2023-06-13 | |||
| 2023-01-31 | 217.93K shares 10-Q · filed 2023-03-14 | ||||
| 2022-07-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | 5.50K shares derived: sum of 2 quarters · filed 2022-10-31 | 177.04K shares derived: sum of 3 quarters · filed 2022-10-31 | 180.44K shares 10-K · filed 2022-10-31 | |
| 2022-04-30 | 5.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | 177.04K shares derived: sum of 2 quarters · filed 2022-06-14 | 180.44K shares 10-Q · filed 2022-06-14 | ||
| 2022-01-31 | 171.54K shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | 174.94K shares 10-Q · filed 2022-03-17 | |||
| 2021-10-31 | 3.40K shares 10-Q/A · filed 2022-02-28 | ||||
| 2021-07-31 | 1.32K shares 10-K · filed 2022-10-31 | ||||
| 2021-01-31 | 999.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-03-17 | 1.32K shares 10-Q · filed 2021-03-17 | 1.32K shares derived: sum of 3 quarters · filed 2021-10-18 | 1.32K shares derived: sum of 4 quarters · filed 2021-10-18 | |
| 2020-10-31 | 324.00 shares 10-Q · filed 2020-12-15 | 324.00 shares derived: sum of 2 quarters · filed 2021-10-18 | 324.00 shares derived: sum of 3 quarters · filed 2021-10-18 | 324.00 shares derived: sum of 4 quarters · filed 2021-10-18 | |
| 2020-07-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | 0.00 shares derived: sum of 2 quarters · filed 2021-10-18 | 0.00 shares derived: sum of 3 quarters · filed 2021-10-18 | 259.00 shares 10-K · filed 2021-10-18 | |
| 2020-04-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | 0.00 shares derived: sum of 2 quarters · filed 2020-06-09 | 259.00 shares 10-Q · filed 2020-06-09 | ||
| 2020-01-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-05 | 259.00 shares 10-Q · filed 2020-03-05 | |||
| 2019-10-31 | 259.00 shares 10-Q · filed 2019-12-09 | ||||
| 2019-07-31 | 819.00 shares 10-K · filed 2020-10-29 | -819.00 shares 10-K · filed 2019-10-04 | |||
| 2019-01-31 | 48.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12 | 544.00 shares 10-Q · filed 2019-03-12 | |||
| 2018-10-31 | 496.00 shares 10-Q · filed 2018-12-10 | ||||
| 2018-07-31 | 82.00 shares 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |